EXAGEN

exagen-logo

Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE brand, several of which are based on our proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagenโ€™s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including rheumatoid arthritis and lupus. Exagen was established in 2002 and is headquartered in Vista, California.

#SimilarOrganizations #People #Financial #Website #More

EXAGEN

Social Links:

Industry:
Biotechnology Genetics Health Care Health Diagnostics Medical

Founded:
2002-01-01

Address:
Vista, California, United States

Country:
United States

Website Url:
http://www.exagen.com

Total Employee:
101+

Status:
Active

Contact:
888-452-1522

Email Addresses:
[email protected]

Total Funding:
322.63 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome


Similar Organizations

arrepath-logo

ArrePath

ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.

editas-medicine-logo

Editas Medicine

Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.

foundation-medicine-logo

Foundation Medicine

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

iecure-logo

iECURE

iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.

knopp-biosciences-logo

Knopp Biosciences

Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.

pathway-genomics-logo

Pathway Genomics

Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.


Current Advisors List

beto-pallares_image

Beto Pallares Board Member @ Exagen
Board_member
2012-11-01

brian-birk_image

Brian Birk Board Member @ Exagen
Board_member
2008-06-01

wendy-s-johnson_image

Wendy S. Johnson Board Member @ Exagen
Board_member
2020-10-01

ana-hooker_image

Ana Hooker Board Member @ Exagen
Board_member
2021-07-01

not_available_image

Frank Stokes Board Member @ Exagen
Board_member
2021-06-01

bruce-robertson_image

Bruce Robertson Board Member @ Exagen
Board_member
2019-07-01

james-tullis_image

James Tullis Board Member @ Exagen
Board_member
2015-05-01

not_available_image

Tina Nova Board Member @ Exagen
Board_member
2019-07-01

Current Employees Featured

fortunato-rocca_image

Fortunato Rocca
Fortunato Rocca President & CEO @ Exagen
President & CEO
2011-10-01

mark-hazeltine_image

Mark Hazeltine
Mark Hazeltine Chief Operating Officer @ Exagen
Chief Operating Officer
2015-03-01

kamal-adawi_image

Kamal Adawi
Kamal Adawi Chief Financial Officer @ Exagen
Chief Financial Officer
2017-01-01

not_available_image

Debra Jeske Zack
Debra Jeske Zack Chief Medical Officer @ Exagen
Chief Medical Officer
2020-03-01

Founder


cole-harris_image

Cole Harris

waneta-tuttle_image

Waneta Tuttle

Stock Details


Company's stock symbol is NASDAQ:XGN

Investors List

innovatus-capital-partners_image

Innovatus Capital Partners

Innovatus Capital Partners investment in Post-IPO Debt - Exagen

j-hunt-holdings_image

J. Hunt Holdings

J. Hunt Holdings investment in Venture Round - Exagen

h-i-g-biohealth-partners_image

H.I.G. BioHealth Partners

H.I.G. BioHealth Partners investment in Venture Round - Exagen

sun-mountain-capital_image

Sun Mountain Capital

Sun Mountain Capital investment in Venture Round - Exagen

tullis-health-investors_image

Tullis Health Investors

Tullis Health Investors investment in Venture Round - Exagen

innovatus-capital-partners_image

Innovatus Capital Partners

Innovatus Capital Partners investment in Debt Financing - Exagen

cottonwood-technology-fund_image

Cottonwood Technology Fund

Cottonwood Technology Fund investment in Debt Financing - Exagen

tullis-health-investors_image

Tullis Health Investors

Tullis Health Investors investment in Debt Financing - Exagen

sun-mountain-capital_image

Sun Mountain Capital

Sun Mountain Capital investment in Debt Financing - Exagen

the-capital-royalty-fund_image

CRG

CRG investment in Debt Financing - Exagen

Official Site Inspections

http://www.exagen.com Semrush global rank: 3.09 M Semrush visits lastest month: 5.19 K

  • Host name: 36.42.202.35.bc.googleusercontent.com
  • IP address: 35.202.42.36
  • Location: United States
  • Latitude: 38.6583
  • Longitude: -77.2481
  • Timezone: America/New_York

Loading ...

More informations about "Exagen"

Exagen - Crunchbase Company Profile & Funding

Exagenโ€™s goal is to enable providers to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and โ€ฆSee details»

Investor Relations | Exagen

Mar 11, 2025 Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025 โ€ฆSee details»

Exagen Org Chart + Executive Team - The Official Board

Organizational Chart of Exagen. Exagen Org Chart www.exagen.com. has 13 executives +1 โ€ฆSee details»

Exagen - businessabc.net

Feb 25, 2025 Exagen Inc. develops and commercializes various testing products based on its โ€ฆSee details»

Exagen Inc. Company Profile | Vista, CA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Exagen Inc. โ€ฆSee details»

Exagen Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Oct 29, 2024 Exagen has 1 employees at their 1 location and $55.64 m in annual revenue in โ€ฆSee details»

Exagen Inc. - AnnualReports.com

Exagen Inc. reports have an aggregate usefulness score of 4.8 based on 142 reviews. Exagen Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) View 2022 ESG โ€ฆSee details»

Leadership โ€“ Exagen Inc.

Prior to joining Exagen, Mr. Black served as CFO of Standard BioTools, where he played a key โ€ฆSee details»

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2024 โ€ฆ

Dec 31, 2024 About Exagen. Exagen is a leading provider of autoimmune testing and its โ€ฆSee details»

Contact Us - Exagen Inc.

Contact Us Exagen Inc. is committed to providing excellent service to our physicians, patients โ€ฆSee details»

Autoimmune Disease Testing Lab - Life Sciences Company

About Exagen Inc. Exagen is dedicated to transforming the care continuum for patients โ€ฆSee details»

Transforming energy for good - Exagen

Our end-to-end approach means Exagen are on the ground every step of the way, developing, โ€ฆSee details»

Investor Relations | Exagen

Apr 21, 2025 Exagen Inc. Announces Senior Secured Credit Facility with Perceptive Advisors โ€ฆSee details»

Exagen Group - Org Chart, Teams, Culture & Jobs - The Org

View Exagen Group's up-to-date org chart, open roles, and culture details. Find executives, โ€ฆSee details»

Q1 2025 Exagen Inc Earnings Call - Yahoo Finance

1 day ago Earlier today, Exagen Inc released financial results for the quarter ended March 31, โ€ฆSee details»

Exagen Company Profile - Office Locations, Competitors, Revenue โ€ฆ

Exagen has 5 employees at their 1 location and $34.1 m in total funding,. See insights on โ€ฆSee details»

Exagenโ€™s Proprietary Biomarker Technology Enables Physicians to โ€ฆ

Exagen and collaborators spent five years validating the Avise CTD test (the name refers to โ€ฆSee details»

Earnings call transcript: Exagen Inc. Q1 2025 revenue beats โ€ฆ

1 day ago Exagen Inc. reported a record revenue of $15.5 million for Q1 2025, beating the โ€ฆSee details»

Exagen Inc. Reports Record Q1 2025 Revenue Driven by Growth in โ€ฆ

Mar 31, 2025 Exagenโ€™s commercial success depends upon attaining and maintaining โ€ฆSee details»

Exagen Group - Crunchbase Company Profile & Funding

Exagen Group may be growing as it has recently received approval for a 20MW energy storage โ€ฆSee details»

linkstock.net © 2022. All rights reserved